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Multislice CT provides information on coronary luminal narrow-
ing and on the structural abnormalities of the coronary arterial
wall using densitometric analysis. We sought to investigate
the effects of coronary luminal narrowing, structural abnor-
malities of the coronary arterial wall, and cardiovascular risk
factors on regional and global myocardial blood flow (MBF)
reserve. Methods: We studied 68 patients (mean age 6 SD,
61 6 10 y; 41 men, 27 women) with an intermediate proba-
bility of coronary artery disease. We measured the severity
of coronary stenoses and the fibroadipose, fibromuscular,
and calcium components of the coronary arterial wall by
64-row multislice CT coronary angiography. We also mea-
sured regional and global MBF reserve by PET using 13N-
ammonia as a flow tracer at rest and after dipyridamole.
Results: One or more significant coronary stenoses
($50% luminal narrowing) was present in 32 patients
(47%), and nonsignificant stenoses were present in 15
patients (22%). Regional MBF reserve was significantly
different in the territories perfused by normal coronary
arteries, nonsignificant coronary stenoses, and significant
coronary stenoses (P , 0.001). Calcium content was higher
in the coronary arteries with significant or nonsignificant
stenoses (0.95% 6 1.08% and 0.73% 6 0.93%, respec-
tively) than in those without stenoses (0.11% 6 0.38%,
P , 0.001). Significant coronary stenosis (P 5 0.047) and
calcium content (P 5 0.017) were the only independent
determinants of impaired regional MBF reserve using multi-
variate analysis. At multiple logistic regression analysis, the
Framingham risk score, an index of global cardiovascular
risk burden, was the only significant determinant of global
MBF reserve (P 5 0.028). Conclusion: Coronary stenoses
and coronary calcium content independently affect regional
MBF reserve. Framingham risk score is the only significant
determinant of global MBF reserve.
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Coronary blood flow reserve is a recognized indicator of
the functional significance of coronary stenoses (1) and used to
establish the need for coronary revascularization in the case of
intermediate lesions (2). However, the use of absolute measure-
ment of myocardial blood flow (MBF) and MBF reserve by
PET has challenged this concept (3). Although PET-derived
regional MBF reserve is inversely related to the degree of
coronary stenoses, considerable interindividual variability exists
(4,5). Early atherosclerosis (6), the function of downstream
coronary microcirculation (7), and cardiovascular risk burden
(8) have been reported as additional determinants of MBF
reserve. However, the relationship between all these compo-
nents and MBF impairment remains undetermined, mainly be-
cause of the limitations of diagnostic approaches used to date.
Multislice CT (MSCT) and PET have the potential to
better elucidate these relationships. MSCT can provide infor-
mation not only on luminal narrowing but also on structural
abnormalities of the vascular wall by means of densitometric
analysis (9). Furthermore, MSCT can estimate coronary cal-
cium content, an established indicator of atherosclerotic bur-
den (10) and coronary risk (11) and a determinant of MBF
reserve (12). Finally, the densitometric analysis of MSCT can
also provide information regarding the fibroadipose and fibro-
muscular components of the coronary arterial wall, which
may indicate early atherosclerotic damage (9). On the other
hand, PET permits delineation of MBF reserve in the same
patient and with the same image format. Thus, combined
analysis of these 2 image datasets may provide direct assess-
ment of the correlation between the structure of the coronary
artery and MBF regulation in the corresponding downstream
myocardial bed (13).
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Thus, we undertook this study to assess the relationship
between coronary luminal narrowing, coronary wall compo-
nents, cardiovascular risk factors, and regional and global
MBF reserve.
MATERIALS AND METHODS
Patient Population
We studied 68 patients referred for noninvasive cardiac imaging
at our institute because of anginalike chest pain and an inter-
mediate (20%–90%) pretest likelihood of coronary artery disease
(CAD) according to the Diamond and Forrester risk score. Twenty
of these patients were enrolled in the EVINCI multicenter study
(Evaluation of Integrated Cardiac Imaging in Ischemic Heart Dis-
ease), whereas 5 were enrolled in the ARTreat multicenter study
(multilevel patient-specific artery and atherogenesis model for out-
come prediction, decision support treatment, and virtual hands-on
training). Patients underwent a myocardial perfusion PET scan at
rest and under dipyridamole, followed by MSCT coronary angiog-
raphy. Those with at least 1 coronary stenosis of 50% or greater
underwent invasive coronary angiography (ICA). Exclusion crite-
ria were previous percutaneous coronary interventions or bypass
surgery, prior myocardial infarction, valvular heart disease, left
ventricular (LV) dysfunction (LV ejection fraction , 45%), con-
traindication to radiographic contrast medium, atrial fibrillation,
and systemic diseases affecting midterm prognosis. The following
cardiovascular risk factors were recorded for each patient: age,
sex, diabetes mellitus, arterial hypertension, hypercholesterolemia,
low high-density-lipoprotein cholesterol, smoking habit, and obesity.
Accordingly, the Framingham risk score was determined as an indi-
cator of integrated cardiovascular risk (14).
All patients were clinically stable before, during, and between the
PET and MSCT angiography studies. The study protocol was
approved by the local ethics committee; all patients signed an
informed consent form.
PET and MSCT Studies
Patients were asked to fast overnight, avoid caffeine-containing
foods, and withdraw b-blockers in the 24 h preceding the PET
study (performed on a Discovery PET/CT scanner; GE Health-
care). Each acquisition was preceded by a CT transmission scan
for photon attenuation correction (15). 13N-ammonia was admin-
istered intravenously at a dose of 7.4 MBq/kg of body weight over
a 10- to 20-s period. Twenty-eight dynamic frames were acquired
over 8 min (16 frames for 3 s, 11 frames for 12 s, and 1 frame for
300 s). Fifty minutes after the baseline study, another CT trans-
mission scan was obtained, and dipyridamole was administered
intravenously (0.56 mg/kg of body weight over 4 min). The dy-
namic 13N-ammonia scan was started 2 min after the completion
of the dipyridamole infusion. Two to 3 min after 13N-ammonia
injection, dipyridamole was antagonized by intravenous amino-
phylline in all patients. A 3-lead electrocardiogram was continu-
ously monitored, and a 9-lead electrocardiogram and arterial
blood pressure were obtained during 13N-ammonia injection at
rest, during dipyridamole infusion, and in the recovery phase.
The whole PET protocol allowed us to limit mean radiation expo-
sure to 3 mSv.
Within 1–6 wk from the completion of each PET study (20 6
18 d), patients underwent 64-slice MSCT coronary angiography
(LightSpeed VCT 64; GE Healthcare) with the following scan
parameters: retrospective electrocardiogram gating, 912 channel
detectors along the gantry and 64 channel detectors along the
z-axis, tube voltage of 120 kV, tube current of 350–750 mA
(depending on patient size), a scan field of view of 50 cm, gantry
rotation of 0.35 s/rotation, a matrix of 512 · 512, a slice thickness
of 0.625 mm, and a range of helical pitch of 0.18–0.24. When
appropriate, metoprolol (up to 5 mg intravenously)—to lower the
heart rate below 65 beats per minute—and isosorbide dinitrate
(up to 1 mg intravenously)—to guarantee maximal epicardial
vasodilatation—were administered. Nonionic iodinated contrast
medium (Iomeprol 400; Bracco) was injected via a peripheral
vein according to a triphasic protocol using a programmable
injector (Nemoto Dual Shot Injector; Nemoto Kyorindo Co.
Ltd.): first a rapid injection of contrast medium (from 5 to 8
mL/s) was administered; in the second phase, 10 mL of contrast
at 1 mL/s were injected simultaneously with 25 mL of saline at
2.5 mL/s; finally, a 35-mL saline flush was administered at 4
mL/s (maximal total volume of contrast medium, 110 mL). To
time the scan, a region of interest was placed in the right ven-
tricular cavity to detect peak contrast enhancement. Scans were
obtained during breath hold; patients were monitored continu-
ously through single-lead electrocardiography. The scan param-
eters were programmed to limit radiation exposure to 15 mSv on
average. After the procedure, patients were infused with saline
(500 mL) to prevent contrast-induced nephropathy and instructed
to have their serum creatinine rechecked between 2 and 7 d after
the examination.
PET and MSCT Analysis
MBF was calculated from PET images according to a
previously validated method (16,17). Segmental MBFs were first
computed according to the standardized 17-segment LV model
(18). Then, patients’ MSCT angiography images were fused with
the pertinent PET volumetric perfusion images using a dedicated
software program (CardIQ Fusion; GE Healthcare) ( ½Fig: 1Fig. 1) that
allowed coregistration of MSCT and PET images by a semiauto-
matic approach. Each myocardial segment was assigned to the
respective major coronary branch (left anterior descending, cir-
cumflex, right coronary artery) (13). MBF reserve in each per-
fusion territory and for the whole left ventricle was computed as
the ratio of MBFs during hyperemia and at rest and considered
depressed if less than 2. The summed stress scores (SSS), summed
rest scores, and summed difference scores were calculated auto-
matically for the left ventricle by dedicated software (Emory Car-
diac Toolbox for PET/CT; GE Healthcare). An SSS greater than 4
was considered indicative of significant stress-induced regional
ischemia (19).
FIGURE 1. Fusion of MSCT
coronary angiography image
(left anterior descending visu-
alization) with pertinent volu-
metric PET perfusion image.
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Transaxial MSCT images were reconstructed using a slice
thickness of 0.625 mm and 0.4-mm increments. The data were
then transferred to a dedicated workstation (Advantage Work-
station 4.3; GE Healthcare) for postprocessing. Lumen size (di-
ameter and area) of the major coronary arteries was measured on
Multiplanar Reformatting Images using an automatic interactive
program to quantify coronary luminal narrowing. The severity of
coronary stenoses was expressed with intervals of 5%; a lumen
reduction 50% or greater was considered a significant stenosis. In
vessels showing multiple stenoses in series, only the most severe
was considered. Volumetric analysis of the coronary vessel wall was
evaluated using the Color Code Plaque analysis software (GE
Healthcare) (9). This densitometric method, based on the Houns-
field scale, allows the computation of a cylindric volume around the
vessel lumen to assess the relative contribution of calcium, fibroa-
dipose, and fibromuscular components to the vessel wall. A similar
algorithm has already been validated against intravascular ultra-
sound, the gold standard for the invasive assessment of vessel wall
structure, using both 64-slice MSCT (20) and dual-source CT scan-
ners (21). The algorithm of vessel wall analysis was calibrated in
each patient according to densitometric parameters measured by a
region of interest in the aortic root, LV myocardium, and epicardial
fat. CT density less than 60 Hounsfield units (HUs) was attributed
to a fibroadipose component and CT density between 60 and 200
HUs to a fibromuscular component, and calcified plaques were
differentiated from the lumen when they had a density greater than
800 HUs using this system (½Fig: 2 Fig. 2). The program output gave a
quantitative (mm3) measurement of fibroadipose, fibromuscular,
and calcium components for each main coronary vessel and for
the entire coronary tree. Each component was expressed as percent-
age of vessel volume and used in per-vessel analyses. The percent-
age of each component in the whole coronary tree was used in the
per-patient analyses.
ICA
Conventional ICA was performed using standard techniques
and standard multiple projections. Coronary angiograms were
quantified with dedicated computer software (Advanced Vessel
Analysis, Innova 3DXR for Advanced Workstations; GE Health-
care) using an automatic edge-contour detection algorithm to
compute stenosis severity expressed in percentage and coronary
minimal luminal diameter. A coronary stenosis of 50% or greater
was considered significant.
Statistical Analysis
Continuous variables were expressed as mean 6 SD and cate-
goric variables as percentages. Simple regression analysis was
used to correlate MSCT variables with regional MBF reserve
and Framingham risk score. Groups were compared for categoric
data using the Fisher exact test and for continuous variables using
ANOVA followed by a Fisher protected least-significant differ-
ence test for multiple comparisons. The Kruskal–Wallis test,
followed by the Dunn test, was used to analyze the prevalence
of the coronary calcium component in the different vessel cat-
egories. Multiple logistic regression analysis was used to iden-
tify the variables significantly associated with depressed (,2)
regional and global MBF reserve. The predictive value of a
variable was expressed as an odds ratio with corresponding
95% confidence interval; the Wald test was used for signifi-
cance. When volumetric characterization of vessel wall compo-
nents was not technically feasible, nonanalyzable vessels and
related patients were excluded from the regression analysis. All
tests were 2-sided. A P value of less than 0.05 was considered
statistically significant. All statistical analyses were performed
using JMP statistical software (version 9.0; SAS Institute Inc.)
and Stata statistical software (release 10; StataCorp. 2007).
RESULTS
Patient-by-Patient Analysis
TheMSCT protocol was completed for every patient without
significant adverse events. Mean heart rate before the procedure
was 59 beats per minute (range, 46–74 beats per minute);
b-blockers were administered in 15 patients. Presence and
severity of coronary stenoses were evaluated in each of the
204 vessels analyzed; because of inadequate image quality in
8 vessels (5 patients), the volumetric characterization of vessel
wall components was obtained in only 196 of 204 vessels
(93%). Coronary angiography by MSCT documented signifi-
cant coronary stenoses ($50% luminal diameter reduction) in
at least 1 major coronary branch in 32 patients (47%), non-
significant stenoses (,50% diameter reduction) in 15 patients
(22%), and normal coronary arteries in 21 patients (31%). In
the 32 patients with significant coronary stenoses, the lesions
involved a single vessel in 16 patients, 2 vessels in 9 patients,
and 3 vessels in 7 patients. ICA confirmed significant stenoses
FIGURE 2. Densitometric analysis of cor-
onary wall structure based on Hounsfield
scale; calcium, fibroadipose, and fibromus-
cular components. CC 5 calcium compo-
nent; FAC 5 fibroadipose component;
FMC 5 fibromuscular component.
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detected at MSCT in 27 of 32 patients (84%) and in 48 of 55
vessels (87%). Accordingly, 5 of 32 patients and 7 of 55 vessels
were excluded from further analysis.
The demographic, clinical, and PET data of the study
patients are summarized in½Table 1 Table 1. Patients with coronary
stenosis (either nonsignificant or significant) were older, had a
higher pretest probability of CAD, and more frequently had
inducible ischemia (SSS. 4) and a reduced MBF reserve than
patients with normal coronary arteries. Among patients with co-
ronary stenoses, the presence of significant lesions did not deter-
mine significant differences for any of the variables explored.
Vessel Structure and Regional MBF Reserve
Of the 197 coronary arteries analyzed, 48 (25%) showed
a significant stenosis and 38 (19%) a nonsignificant stenosis,
whereas 111 (56%) did not show any stenosis. Regional
MBF reserve was significantly different in the territories
perfused by normal coronary arteries (2.136 0.54) from that
in areas of nonsignificant (1.91 6 0.58) and significant cor-
onary stenosis (1.63 6 0.51, P , 0.001). Similarly, the
calcium content was higher in the arteries with significant
(0.95% 6 1.08%) or nonsignificant stenoses (0.73% 6
0.93%) than in those without stenoses (0.11% 6 0.38%,
P , 0.001). Conversely, the fibroadipose and fibromuscular
components did not significantly differ between the various
vessel categories ( ½Fig: 3Fig. 3).
Determinants of Regional MBF Reserve
Regional MBF reserve was negatively correlated with the
severity of coronary stenosis at MSCT (R 5 20.36) ( ½Fig: 4Fig.
4). In patients in whom quantitative ICA data were avail-
able, the correlation between regional MBF reserve and
stenosis severity was confirmed (Supplemental Fig. 1; sup-
plemental materials are available online only at http://jnm.
snmjournals.org). Regional MBF reserve was also negatively
correlated with coronary calcium content (R 5 20.32) and
the coronary fibroadipose component (R 5 20.20) (Fig. 4)
but not with the fibromuscular component. On multiple logis-
tic regression analysis, significant coronary stenoses (P ,
0.047) and coronary calcium content (P , 0.017) remained
the only independent determinants of regional MBF reserve
( ½Table 2Table 2), because of the internal correlation between coro-
nary calcium and fibroadipose content (R 5 0.25, P 5 0.01).
Interestingly, the fibroadipose component of the arterial wall
TABLE 1
Characteristics of Patients
Parameter
Overall
(n 5 63)
Normal arteries
(n 5 21)
,50% stenosis
(n 5 15)
$50% stenosis
(n 5 27) P
Age (y) 62 6 11 56 6 9 62 6 12 66 6 11* 0.014
Male sex 37 (59) 10 (48) 10 (67) 17 (63) 0.436
Typical angina 44 (70) 12 (57) 11 (73) 21 (77) 0.286
Pretest probability of CAD (%) 58.4 6 27.0 45.6 6 28.5 54.2 6 27.0† 65.3 6 20.4* 0.022
Family history of coronary heart disease 17 (30) 6 (29) 4 (27) 7 (26) 0.978
Diabetes mellitus 11 (17) 3 (14) 2 (13) 6 (22) 0.787
Hypercholesterolemia 28 (44) 12 (57) 5 (33) 11 (41) 0.321
Low high-density-lipoprotein cholesterol 27 (43) 7 (33) 7 (47) 13 (48) 0.545
Hypertension 24 (38) 5 (24) 7 (47) 12 (44) 0.253
Obesity 9 (14) 2 (10) 5 (33) 2 (7) 0.056
Smoking 16 (25) 7 (33) 1 (7)† 8 (29) 0.155
Framingham risk score (%) 14.1 6 11.3 10.4 6 6.3 12.9 6 10.1 17.7 6 13.6† 0.091
LV ejection fraction (%) 57 6 11 59 6 13 55 6 12 56 6 9 0.514
LV end-diastolic volume (mL) 136 6 36 133 6 35 139 6 42 136 6 34 0.902
LV end-systolic volume (mL) 58 6 30 55 6 37 56 6 22 62 6 26 0.774
Summed rest score 5.9 6 7.5 4.3 6 5.0 6.3 6 8.2 7.1 6 8.6 0.483
Summed stress score 8.2 6 8.1 6.2 6 6.6 7.6 6 8.4 10.7 6 9.2 0.186
Summed stress score . 4 35 (56) 7 (33) 8 (53) 20 (74)† 0.019
Summed difference score 2.5 6 3.3 1.9 6 2.9 1.4 6 2.6 3.6 6 3.8 0.079
MBF reserve 2.0 6 0.5 2.2 6 0.5 2.1 6 0.6 1.8 6 0.5† 0.044
MBF reserve , 2 33 (52) 6 (29) 9 (60) 18 (66)* 0.025
b-blockers 21 (33) 6 (29) 4 (27) 11 (41) 0.554
Calcium channel blockers 11 (17) 3 (14) 2 (13) 6 (22) 0.687
Nitrates 14 (22) 1 (5) 5 (33)† 8 (30)† 0.059
Diuretics 6 (9) 2 (9) 3 (20) 1(4) 0.226
Angiotensin-converting enzyme inhibitors
or angiotensin receptor blockers
22 (35) 7 (33) 4 (27) 11 (41) 0.645
Statins or fibrates (n) 21 (33) 4 (19) 5 (33) 12 (44)† 0.180
Aspirin 25 (40) 8 (38) 6 (60) 13 (48) 0.758
*P , 0.01 vs. normal.
†P , 0.05 vs. normal.
Data are mean 6 SD, or n with percentages in parentheses.
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was a determinant of MBF reserve only in the presence of
coronary stenoses (½Fig: 5 Fig. 5A).
Correlation Between Atherosclerotic Burden and
MBF Reserve
MBF reserve was markedly heterogeneous (range, 1.24–
3.61) in regions perfused by vessels without a significant
stenosis. This variability was largely explained by the ath-
erosclerotic burden of each vessel, estimated by the degree
of coronary calcium content. In fact, a correlation was
found between the amount of coronary calcium content and
downstream MBF reserve in vessels without a significant
stenosis (R 5 20.28, P 5 0.006) but not downstream from
significantly stenotic vessels (R 5 20.20, P 5 0.10) (Fig.
5B).
Determinants of Global MBF Reserve
Global coronary calcium content was an independent
determinant of reduced global MBF reserve after adjust-
ment for major cardiovascular risk factors, LV ejection
fraction, and other MSCT parameters using multivariate
analysis (P5 0.045, ½Table 3Table 3). However, when the Framing-
ham risk score, an indicator of integrated cardiovascular
risk, was used, it was the only significant determinant of
global MBF reserve (odds ratio, 1.18 [95% confidence
interval, 1.02–1.37], P 5 0.028), overwhelming the effect
of MSCT variables in the predictive model. Interestingly,
the Framingham risk score was significantly correlated with
the fibroadipose component (R5 0.43) and calcium content
(R 5 0.41) of the whole coronary tree but not with the
presence and number of significant coronary stenoses.
FIGURE 3. Regional MBF reserve and rel-
ative prevalence of coronary calcium, fibro-
adipose, and fibromuscular components in
different vessel categories. CC 5 calcium
component; FAC 5 fibroadipose compo-
nent; FMC 5 fibromuscular component.
FIGURE 4. Stenosis severity, coronary
calcium component, and coronary fibroadi-
pose component vs. downstream regional
MBF reserve. CC 5 calcium component;
FAC 5 fibroadipose component.
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DISCUSSION
This study shows that an abnormal coronary wall
structure affects regional MBF reserve beyond the presence
and severity of coronary stenoses. Specifically, calcium
content was the main determinant of impaired regional
MBF reserve, whereas the fibroadipose component of the
vessel wall was related with MBF reserve only in the
presence of coronary stenoses. Interestingly, both calcium
and fibroadipose components of the whole coronary tree
were significantly related to individual cardiovascular risk
burden. Accordingly, the Framingham risk score was the
only independent determinant of global MBF reserve.
Determinants of Regional MBF Reserve: Coronary
Stenosis and Vessel Structure
The relationship between coronary stenosis and regional
MBF reserve was first documented by Gould and Lipscomb
(1). This original concept, although validated in humans
using angiographic estimates of stenosis severity and mea-
surement of MBF reserve by PET (4), has been recently
questioned (3). In fact, PET studies have shown an unex-
pected variability of downstream MBF reserve in vessels
that were mildly stenotic and even in angiographically nor-
mal coronary arteries (5). Moreover, even fractional flow
reserve, considered the reference method for assessing the
functional significance of coronary stenoses, correlates poorly
with the degree of luminal narrowing measured by invasive
angiography or MSCT (22,23). Possible interpretations in-
clude the inaccuracy of angiographic measures of coronary
stenoses, an abnormal MBF regulation (24,25), endothelial
dysfunction (26), the effect of diffuse atherosclerosis on
coronary flow (27), or structural and functional abnormal-
ities of coronary microcirculation (8).
In the present study, although MBF reserve was neg-
atively related to the degree of coronary stenoses, individ-
ual data were rather dispersed, mainly downstream from
nonsignificant stenoses or in normal vessels. This varia-
bility was partly explained by coronary calcium content.
Within the wall of vessels without significant stenoses,
calcium content may express the presence of early athero-
sclerosis, which in turn impairs downstream myocardial
perfusion (26). A similar correlation has been reported by
Curillova et al. (12), although the presence and extent of
coronary stenoses was not directly evaluated in that study
TABLE 2
Determinants of Depressed Regional MBF Reserve
Logistic regression
Univariate Multivariate
Variable Odds ratio 95% confidence interval P Odds ratio 95% confidence interval P
Stenosis $ 50%, 0–1 2.98 1.49–5.97 0.002 2.11 1.01–4.46 0.047
Calcium component (%) 2.10 1.32–3.27 0.001 1.80 1.11–2.92 0.017
Fibroadipose component (%) 1.03 1.01–1.08 0.046 1.02 0.98–1.07 0.214
Fibromuscular component (%) 0.98 0.95–1.01 0.203 0.99 0.96–1.02 0.471
FIGURE 5. (A) Coronary fibroadipose
component vs. regional MBF reserve in cor-
onary arteries without stenoses (left) and
coronary arteries with stenoses (right). (B)
Coronary calcium component vs. down-
stream regional MBF reserve in vessels that
were normal or without significant stenoses
(left) and vessels with significant stenoses
(right). CC 5 calcium component; FAC 5
fibroadipose component.
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and, as a result, the relative contribution of abnormal wall
structure and luminal narrowing could not be established.
An additional novel finding of our study was that a higher
fibroadipose component of the coronary wall was correlated
with a reduction of downstream MBF reserve in the presence
of luminal coronary narrowing. The clinical and patho-
physiologic relevance of this result remains unclear. An
increased fibroadipose component might highlight func-
tionally active coronary atherosclerosis (28) or indicate the
presence of widespread atheroma along the entire coronary,
a condition that may additively impair myocardial per-
fusion even in the presence of focal stenoses (27,29).
Determinants of Global MBF Reserve: Role of
Cardiovascular Risk Factors
It is widely accepted that cardiovascular risk factors can
impair myocardial perfusion even in the absence of sig-
nificant coronary stenosis (30,31) and that globally de-
pressed MBF reserve negatively affects patient outcome
beyond the extent of coronary artery disease (32). Although
the consecutive pathogenetic link between risk factors,
stenotic coronary disease, and depressed MBF reserve is
accepted, the mechanisms of a possible direct effect of
these factors on coronary function are still debated.
In our study, coronary calcium content was the major
determinant of depressed global MBF reserve after adjust-
ment for individual cardiovascular risk factors, extent of
coronary disease, and LV ejection fraction. However, when
risk factors were integrated into the Framingham risk score,
this indicator of global cardiovascular risk turned out to be
the only significant predictor of depressed global MBF
reserve, overwhelming the effect of coronary calcium. This
observation extends to previous reports on the association
between Framingham risk score and global MBF reserve in
patients without coronary stenoses (8), showing that a
higher cardiovascular risk burden remains an independent
predictor of depressed global MBF reserve, even in patients
with different degrees of coronary disease.
Study Limitations
This study has several limitations. Because of the
relatively limited sample size and lack of an invasive
assessment of coronary wall structure and function, as
provided by intravascular ultrasound and fractional flow
reserve (33), the accuracy of combined MSCT and PET in
detecting different stages of CAD could not be evaluated.
However, the main purpose of the study was not to optimize
the diagnostic application of PET/CT, but rather to non-
invasively assess the relationships between coronary steno-
sis, wall structure, and altered MBF reserve. In addition,
calcium content was measured from MSCT angiography
without evaluating the Agatston calcium score, thus reduc-
ing radiation exposure by about 10%.
The presence of contrast within the lumen might have
limited the ability to differentiate vessel wall components.
Nevertheless, the selection of an appropriate window level
allowed the differentiation of contrast inside the coronary
lumen from fibroadipose (,60 HU), fibromuscular (60 to
200 HU), and calcium (.800 HU) components. Although
the reduction of the window of HU for calcium recognition
may have caused an underestimation of calcium volume
(20), unpublished data from our laboratory (collected from
2008 to 2011) show a strong correlation between the
present method and the Agatston score (y 5 1.47 1
0.128x; R2 5 0.874, F250 5 660.6, P , 0.0001).
Another limitation is that the presence of calcium may
have limited the ability of MSCT in evaluating stenosis
severity. In reality, the effect of calcium on MBF reserve
could be demonstrated downstream from coronary arteries
independently of the extent of detected luminal narrowing.
TABLE 3
Determinants of Depressed Global MBF Reserve
Logistic regression
Univariate Multivariate
Variable Odds ratio 95% confidence interval P Odds ratio 95% confidence interval P
Age (n) 1.02 0.97–1.06 0.498 1.04 0.85–1.03 0.529
Sex (male) 1.38 0.52–3.64 0.521 3.69 0.93–1.16 0.233
Family history of CAD, 1–0 0.64 0.22–1.82 0.399 1.58 0.24–10.19 0.633
Smoking, 1–0 1.37 0.45–4.17 0.576 4.81 0.32–22.67 0.257
Diabetes mellitus, 1–0 2.00 0.54–7.41 0.299 1.11 0.09–2.89 0.084
Hypercholesterolemia, 1–0 1.86 0.71–4.91 0.209 2.13 0.74–6.19 0.164
Low high-density-lipoprotein
cholesterol, 1–0
2.19 0.81–5.96 0.126 2.17 0.78–6.21 0.071
Hypertension, 1–0 1.76 0.65–5.76 0.266 0.56 0.20–12.39 0.676
Obesity (body mass index . 30), 1–0 0.96 0.83–1.09 0.475 0.97 0.73–1.27 0.799
Left ventricular EF, (%) 0.98 0.94–1.04 0.589 1.02 0.92–1.12 0.765
Significant coronary stenosis (n) 1.73 1.02–2.92 0.040 2.79 0.79–9.81 0.111
Global calcium component (%) 2.33 1.03–5.26 0.041 2.34 1.01–5.39 0.045
Global fibroadipose component (%) 1.04 0.98–1.11 0.188 0.99 0.89–1.12 0.949
Global fibromuscular component (%) 0.97 0.93–1.03 0.399 0.95 0.84–1.07 0.384
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In our study, only patients with at least 1 significant
coronary stenosis underwent ICA. Thus, we were not able
to test the accuracy of MSCT angiography in assessing the
severity of nonsignificant lesions. However, all of the 14
nonsignificant stenoses demonstrated at MSCT for patients
with a significant lesion in another coronary artery were
confirmed by ICA.
Summed rest score and SSS showed a high interindivid-
ual variability, even in patients without significant coronary
stenoses. Because of the elevated negative predictive value
of MSCT (34), it is improbable that missed significant
lesions might explain this result. On the other hand, a sim-
ilarly high interindividual variability has been demonstrated
in regional MBF reserve downstream from vessels without
significant stenosis, suggesting a functional impairment of
coronary macro- or microcirculation as a probable cause of
both findings (35).
Finally, although we usually perform MSCT and PET
within the same session for clinical purposes (thus allowing
the PET examination to be avoided if MSCT is negative),
we separated the 2 imaging modalities for research pur-
poses. However, because treatment was unchanged and the
imaging coregistration process was unaffected by this ap-
proach, we do not believe that results have been substan-
tially influenced.
CONCLUSION
This study shows that regional MBF reserve is an
integrated measurement of the anatomic and functional
effects of coronary atherosclerosis on flow regulation. Both
luminal stenosis and structural abnormalities of the coro-
nary wall were associated with impaired downstream myo-
cardial perfusion. The assessment of absolute MBF reserve
by PET, integrated with the evaluation of coronary anatomy
and structure by MSCT, provides overall information on the
functional relevance of the atherosclerotic process.
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